TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Jacobson Pharma Corporation Limited ( (HK:2633) ) has shared an update.
Jacobson Pharma Corporation Limited has announced a positive profit alert, expecting a more than 40% increase in profit from continuing operations for the fiscal year ending March 2025 compared to the previous year. This growth is attributed to strong performance in specialty medicines and generic drugs, new product launches, and effective cost control measures. Additionally, the profit attributable to equity shareholders is anticipated to rise by over 10%, following the distribution of JBM Healthcare shares as a special dividend.
More about Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited operates in the pharmaceutical industry, focusing on specialty medicines and generic drugs. The company is known for its robust product launches and in-licensed products, contributing significantly to its revenue.
Average Trading Volume: 941,368
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.41B
For detailed information about 2633 stock, go to TipRanks’ Stock Analysis page.